As we already mentioned, AGEs and AGE-activated RAGE, concomitant with glycation and inflammation, could potentially function as metabolic and molecular signatures of malignant or metastatic cancers, and hence can be exploited as potent biomarkers, pertinent to cancer stage and individual tissue-specific expression. This evidence concerns the gene AGER and metastatic malignant neoplasm.